Regencell Bioscience Faces Securities Class Action Lawsuit

A securities class action lawsuit has been filed against Regencell Bioscience Holdings Limited (NASDAQ: RGC), alleging that company officials issued false or misleading statements during the period from October 28, 2024 to October 31, 2025. The case claims these actions exposed investors to financial risk and regulatory scrutiny.

By The Gross Law Firm · PR Newswire · June 2, 2026, 13:00 UTC

Tickers: $RGC

Topics: class action Regencell Bioscience Holdings Limited shareholder lawsuit

Read the full article at PR Newswire

More Politics news

Class Action Lawsuit Filed Against Skechers U.S.A., Inc. Regarding Take-Private Acquisition PR Newswire · November 12, 2026, 15:00 UTC
Class Action Lawsuit Filed Against Compass, Inc. Regarding Merger Disclosures PR Newswire · November 12, 2026, 15:00 UTC
Scott Colom Defeats Incumbent Cindy Hyde-Smith in Mississippi Senate Election CNBC · November 11, 2026, 23:03 UTC
Advocacy Groups Prepare to Pressure Politicians Over Data Center Restrictions Following Midterm Elections The Verge · November 11, 2026, 21:56 UTC
Alleged Security Concerns Involving Nvidia CEO Jensen Huang Prompt US-Taiwan Official Concern The Verge · November 11, 2026, 19:22 UTC
Scott Colom Maintains Narrow Lead Over Cindy Hyde-Smith in Mississippi Senate Race CNBC · November 10, 2026, 21:55 UTC
Jim Jordan Elected House Republican Minority Leader CNBC · November 10, 2026, 19:55 UTC
President Trump Replaces WeatherTech Founder with Agency Veteran for FTC Nomination The Verge · November 10, 2026, 14:46 UTC
Republican Leadership Divided Over Causes of Midterm Election Losses CNBC · November 10, 2026, 11:00 UTC
Donald Trump Makes Unannounced C-SPAN Appearance Following Midterm Election Losses CNBC · November 10, 2026, 06:19 UTC